Product Information
REPATHA 140 MG/ML SYRINGE is a brand product labeled by Amgen Inc., priced at $281.6973 per ML under NDC 72511075001. Its NADAC has been published 363 times since Jul 17, 2019.
Strength
140 mg/mL
Manufacturer
Amgen Inc.NDC
72511075001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
EVOLOCUMABApproval Type
Biologic (BLA)
FDA Application
BLA125522On Market Since
10/9/2018
Pharmacological Classes
Price Statistics
The NADAC for REPATHA 140 MG/ML SYRINGE has been published 363 times since Jul 17, 2019, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $281.6973 per ML |
|---|---|
| All-time high | $281.9135 (Jun 10, 2026) |
| All-time low | $216.6720 (Sep 18, 2019) |
| 52-week high | $281.9135 |
| 52-week low | $275.5845 |
| Median price | $251.2171 |
| Average price | $250.7094 |
| Largest weekly change | +5.9% (Feb 3, 2021) |
| Weeks tracked | 363 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPATHA 140 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for REPATHA 140 MG/ML SYRINGE, manufactured by Amgen Inc., is $281.6973 per ML (NDC 72511075001), effective Jun 24, 2026.
How has the price of REPATHA 140 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for REPATHA 140 MG/ML SYRINGE has risen 29.0%. It has been tracked across 363 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for REPATHA 140 MG/ML SYRINGE?
Since Jul 17, 2019, the NADAC for REPATHA 140 MG/ML SYRINGE has ranged from a low of $216.6720 (Sep 18, 2019) to a high of $281.9135 (Jun 10, 2026), with a median of $251.2171 per ML.
Are there cheaper alternatives to REPATHA 140 MG/ML SYRINGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as REPATHA 140 MG/ML SYRINGE, but none are currently priced below it.
Who manufactures REPATHA 140 MG/ML SYRINGE?
REPATHA 140 MG/ML SYRINGE (NDC 72511075001) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification